Učitavanje...
Single‐dose pharmacokinetic study comparing the pharmacokinetics of recombinant human chorionic gonadotropin in healthy Japanese and Caucasian women and recombinant human chorionic gonadotropin and urinary human chorionic gonadotropin in healthy Japanese women
PURPOSE: Recombinant hCG (r‐hCG) was approved in Japan in 2016. As a prerequisite for a Phase III study in Japan related to this approval, the pharmacokinetic (PK) profile of r‐hCG was investigated. METHODS: An open‐label, partly randomized, single‐center, single‐dose, group‐comparison, Phase I PK‐b...
Spremljeno u:
| Izdano u: | Reprod Med Biol |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5768983/ https://ncbi.nlm.nih.gov/pubmed/29371821 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rmb2.12066 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|